Login
Search result (1-20 of 86)Download
|
Symbol
|
RMA0EV | RMA72V | RMBM8V | RMASDV | ABWQSQ | CHLBKB | ABITTQ | RMBQ3V | RMBQ5V | PEYRCH | CGJBKB | PGJRCH | RMBHUV | ABJTTQ | ABNSTQ | RMBRSV | RMA7JV | ABOMTQ | RMBAIV | PKRRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible |
|
Underlying
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | Roche PS / Sonova Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Helvetia Baloise Holding AG / Ypsomed Hldg. AG / Sandoz Group AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Bachem Hldg. AG / Sandoz Group AG / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Roche PS / Siegfried Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | DOCMORRIS AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Alcon / Lonza Group N / Ypsomed Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
15.06.2026 | 31.08.2026 | 27.04.2026 | 11.05.2026 | 08.05.2026 | 11.05.2026 | 06.05.2026 | 18.05.2026 | 17.11.2026 | 18.05.2026 | 05.05.2026 | 22.05.2026 | 01.06.2026 | 12.05.2026 | 26.05.2026 | 22.05.2026 | 21.12.2026 | 03.06.2026 | 30.12.2026 | 30.06.2026 |
| Bid | 25.000 | 70.90 | - | 68.10 | 57.02 | 102.06 | 74.04 | 98.70 | 38.400 | 70.19 | 101.50 | 57.48 | 68.60 | 70.75 | 79.44 | 47.000 | 92.20 | 60.50 | 45.600 | 97.45 |
| Ask | - | - | - | - | - | 102.88 | - | 100.30 | - | - | - | - | - | - | - | - | - | - | - | - |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)